Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-24
1994-02-08
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, A61K 31445
Patent
active
052848566
ABSTRACT:
Compounds of the formula I ##STR1## in which the substituents R.sub.1 -R.sub.5 and n and m are as defined are suitable for controlling tumors.
REFERENCES:
patent: 3629290 (1971-12-01), Cairns
patent: 4603137 (1986-07-01), Bhat et al.
patent: 4900727 (1990-02-01), Kattige
Mutschler, E., "Arzneimittelwirkungen: Lehrbuch der Pharmakologie und Toxikologie: mit einfuhrenden Kapiteln in die Anatomie, Physiologie und Pathophysiologie", Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1991, pp. 656-661.
Murray, K., et al., "Protein Kinases, in Hensch, C., Comprehensive M.C.", pp. 531-533. (date not available and cannot be acertained).
Organikum [Laboratory Practice in Organic Chemistry], VEB, Deutscher Verlag der Wissenschaften, 15th edition, Berlin 1977, Chapter D7, pp. 475-477.
Chemical Abstracts 108 183888m, 1988, p. 438.
Chemical Abstracts 106 38467c, 1987, p. 359.
Dickneite Gerhard
Lal Bansi
Naik Ramchandra G.
Rupp Richard H.
Sedlacek Hans H.
Haley Jacqueline
Hoechst Aktiengesellschaft
Lee Mary C.
LandOfFree
Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-698148